This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
RNA breakthroughs, Case Studies and Partnerships
September 23-24, 2026Thomas M. Menino Convention & Exhibition Center
Menu
Key Sessions
Jay Stella
PANEL: Pharma Partnerships
Strand Therapeutics Inc
Clay Alspach
PANEL: Navigating the Geopolitical Climate and Challenges of mRNA in the US
Alliance for mRNA Medicines
Fred Fleitz
PANEL: Bridging the Gap: Addressing Regulatory Challenges in Oligonucleotide Development
Arrowhead Pharmaceuticals
Bao Cai, PhD
PRESENTATION: Building a Scalable and Compliant RNAi Therapeutics Program
Sarepta Therapeutics
Thaminda Ramanayake
PANEL: Progressing mRNA-based Therapeutics and Vaccines to Combat Cancer
CureVac
Sally Werner
PRESENTATION: Advancing mRNA for Cancer – The Patient Perspective
Cancer Support Community
keyboard_arrow_right

Day 2- Thursday, September 11th - EST (Eastern Time, UTC-05:00

keyboard_arrow_leftSearch & Filter
close
Day 2- Thursday, September 11th - EST (Eastern Time, UTC-05:00
close
Showing 1 of 1 Streams
9:05am - 9:50am
PANEL: Bridging the Gap: Addressing Regulatory Challenges in Oligonucleotide Development

  • Discuss current regulatory hurdles and evolving guidelines impacting oligonucleotide drug development

  • Explore strategies for navigating regulatory pathways and fostering collaboration between industry, patient advocacy groups and regulatory agencies

  • Examine best practices for demonstrating safety, efficacy, and quality of oligonucleotide therapeutics throughout the development lifecycle

  • Fred Fleitz - Group Vice President, CMC, Arrowhead Pharmaceuticals
  • YanLing He, DMSci. PhD. - Executive Director, TM Profiling Head CVM, Novartis
  • Bao Cai, PhD - Former Executive Director, Process Development, Sarepta Therapeutics
  • Shiva Adhikari - Lead Senior Scientist, Process Development, Axolabs
Showing 1 of 1 Streams
3:20pm - 4:05pm
PANEL: Pharma Partnerships

  • Uncover innovative partnership paradigms and strategic approaches that catalyze breakthroughs and expedite the evolution of RNA-based therapeutics, with a spotlight on emerging opportunities in the Asia-Pacific and European regions and established collaborations in North America.

  • Dissect the critical components of high-impact collaborations among biotech firms, pharmaceutical giants, and key industry players within the global RNA ecosystem.

  • Pinpoint promising avenues and navigate potential hurdles in forging transcontinental strategic alliances, particularly between North American companies to propel RNA research, optimize manufacturing processes, and enhance clinical translation efforts.

  • Examine case studies of successful local and international partnerships that have leveraged diverse expertise, to accelerate RNA therapeutic development and market access. Highlight strategies for fostering robust, long-term collaborations in the RNA pharma landscape.

  • Jay Stella - Chief Business Officer and acting Chief Financial Offer, Strand Therapeutics Inc
  • Karina Thorn - Corporate Vice President, Head of Research, Global Nucleic Acid Therapies Research, Novo Nordisk
  • Michelle Hall - Associate VP - Genetic Medicine Research, Eli Lilly & Company
  • Malgorzata Gonciarz - Global Head xRNA Therapeutics, Novartis
  • Daniel Abernathy - Director, McQuade Center for Strategic Research & Development, Otsuka
Day 1- Wednesday September 10th
Filter
Streams
Formats
Choose Day